Fore Capital, LLC Evotec Se Transaction History
Fore Capital, LLC
- $114 Million
- Q1 2025
A detailed history of Fore Capital, LLC transactions in Evotec Se stock. As of the latest transaction made, Fore Capital, LLC holds 17,005 shares of EVO stock, worth $80,433. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,005Holding current value
$80,433% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding EVO
# of Institutions
24Shares Held
3.06MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.9MShares$9 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT752KShares$3.55 Million1.28% of portfolio
-
Morgan Stanley New York, NY88KShares$416,4330.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$390,6880.0% of portfolio
-
Abc Arbitrage Sa Paris, I077.9KShares$368,5560.05% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.67B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...